Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

LncRNA-mediated regulation of SOX9 expression in basal subtype breast cancer cells.

Tariq A, Hao Q, Sun Q, Singh DK, Jadaliha M, Zhang Y, Chetlangia N, Ma J, Holton SE, Bhargava R, Lal A, Prasanth SG, Prasanth KV.

RNA. 2020 Feb;26(2):175-185. doi: 10.1261/rna.073254.119. Epub 2019 Nov 5.

PMID:
31690584
2.

A natural antisense lncRNA controls breast cancer progression by promoting tumor suppressor gene mRNA stability.

Jadaliha M, Gholamalamdari O, Tang W, Zhang Y, Petracovici A, Hao Q, Tariq A, Kim TG, Holton SE, Singh DK, Li XL, Freier SM, Ambs S, Bhargava R, Lal A, Prasanth SG, Ma J, Prasanth KV.

PLoS Genet. 2018 Nov 29;14(11):e1007802. doi: 10.1371/journal.pgen.1007802. eCollection 2018 Nov.

3.

Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer.

Liu YR, Jiang YZ, Xu XE, Yu KD, Jin X, Hu X, Zuo WJ, Hao S, Wu J, Liu GY, Di GH, Li DQ, He XH, Hu WG, Shao ZM.

Breast Cancer Res. 2016 Mar 15;18(1):33. doi: 10.1186/s13058-016-0690-8.

4.

Expression profile analysis of long noncoding RNA in ER-positive subtype breast cancer using microarray technique and bioinformatics.

Peng J, Zhang L, Yuan C, Zhou L, Xu S, Lin Y, Zhang J, Yin W, Lu J.

Cancer Manag Res. 2017 Dec 14;9:891-901. doi: 10.2147/CMAR.S151120. eCollection 2017.

5.

Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.

Rodríguez Bautista R, Ortega Gómez A, Hidalgo Miranda A, Zentella Dehesa A, Villarreal-Garza C, Ávila-Moreno F, Arrieta O.

Clin Epigenetics. 2018 Jun 27;10:88. doi: 10.1186/s13148-018-0514-z. eCollection 2018. Review. Erratum in: Clin Epigenetics. 2018 Aug 8;10(1):106.

6.

Long non-coding RNA BRAF-regulated lncRNA 1 promotes lymph node invasion, metastasis and proliferation, and predicts poor prognosis in breast cancer.

Jiang J, Shi SH, Li XJ, Sun L, Ge QD, Li C, Zhang W.

Oncol Lett. 2018 Jun;15(6):9543-9552. doi: 10.3892/ol.2018.8513. Epub 2018 Apr 17.

7.

The effects of lncRNA MALAT1 on proliferation, invasion and migration in colorectal cancer through regulating SOX9.

Xu Y, Zhang X, Hu X, Zhou W, Zhang P, Zhang J, Yang S, Liu Y.

Mol Med. 2018 Oct 3;24(1):52. doi: 10.1186/s10020-018-0050-5.

8.

Long noncoding RNA Linc00339 promotes triple-negative breast cancer progression through miR-377-3p/HOXC6 signaling pathway.

Wang X, Chen T, Zhang Y, Zhang N, Li C, Li Y, Liu Y, Zhang H, Zhao W, Chen B, Wang L, Yang Q.

J Cell Physiol. 2019 Aug;234(8):13303-13317. doi: 10.1002/jcp.28007. Epub 2019 Jan 7.

PMID:
30618083
9.

A negative feedback loop between long noncoding RNA NBAT1 and Sox9 inhibits the malignant progression of gastric cancer cells.

Yan J, Huang W, Huang X, Xiang W, Ye C, Liu J.

Biosci Rep. 2018 Nov 15;38(6). pii: BSR20180882. doi: 10.1042/BSR20180882. Print 2018 Dec 21.

10.

Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.

Bamodu OA, Huang WC, Lee WH, Wu A, Wang LS, Hsiao M, Yeh CT, Chao TY.

BMC Cancer. 2016 Feb 25;16:160. doi: 10.1186/s12885-016-2108-5.

11.

SOX9 regulates low density lipoprotein receptor-related protein 6 (LRP6) and T-cell factor 4 (TCF4) expression and Wnt/β-catenin activation in breast cancer.

Wang H, He L, Ma F, Regan MM, Balk SP, Richardson AL, Yuan X.

J Biol Chem. 2013 Mar 1;288(9):6478-87. doi: 10.1074/jbc.M112.419184. Epub 2013 Jan 10.

12.
13.

lncRNA CASC9 positively regulates CHK1 to promote breast cancer cell proliferation and survival through sponging the miR‑195/497 cluster.

Shao G, Wang M, Fan X, Zhong L, Wang Z, Zhang P, Ji S.

Int J Oncol. 2019 May;54(5):1665-1675. doi: 10.3892/ijo.2019.4734. Epub 2019 Feb 28.

14.

C-MYC-induced upregulation of lncRNA SNHG12 regulates cell proliferation, apoptosis and migration in triple-negative breast cancer.

Wang O, Yang F, Liu Y, Lv L, Ma R, Chen C, Wang J, Tan Q, Cheng Y, Xia E, Chen Y, Zhang X.

Am J Transl Res. 2017 Feb 15;9(2):533-545. eCollection 2017.

15.

LncRNA RP11-19E11 is an E2F1 target required for proliferation and survival of basal breast cancer.

Giro-Perafita A, Luo L, Khodadadi-Jamayran A, Thompson M, Akgol Oksuz B, Tsirigos A, Dynlacht BD, Sánchez I, Esteva FJ.

NPJ Breast Cancer. 2020 Jan 6;6:1. doi: 10.1038/s41523-019-0144-4. eCollection 2020.

16.

Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness.

Shin VY, Chen J, Cheuk IW, Siu MT, Ho CW, Wang X, Jin H, Kwong A.

Cell Death Dis. 2019 Mar 20;10(4):270. doi: 10.1038/s41419-019-1513-5.

17.

The long noncoding RNA sONE represses triple-negative breast cancer aggressiveness through inducing the expression of miR-34a, miR-15a, miR-16, and let-7a.

Youness RA, Hafez HM, Khallaf E, Assal RA, Abdel Motaal A, Gad MZ.

J Cell Physiol. 2019 Nov;234(11):20286-20297. doi: 10.1002/jcp.28629. Epub 2019 Apr 9.

PMID:
30968427
18.

SOX9: The master regulator of cell fate in breast cancer.

Jana S, Madhu Krishna B, Singhal J, Horne D, Awasthi S, Salgia R, Singhal SS.

Biochem Pharmacol. 2020 Jan 3;174:113789. doi: 10.1016/j.bcp.2019.113789. [Epub ahead of print] Review.

PMID:
31911091
19.

NFIB promotes cell survival by directly suppressing p21 transcription in TP53-mutated triple-negative breast cancer.

Liu RZ, Vo TM, Jain S, Choi WS, Garcia E, Monckton EA, Mackey JR, Godbout R.

J Pathol. 2019 Feb;247(2):186-198. doi: 10.1002/path.5182. Epub 2018 Dec 18.

PMID:
30350349
20.

Oncogenic long noncoding RNA landscape in breast cancer.

Xu S, Kong D, Chen Q, Ping Y, Pang D.

Mol Cancer. 2017 Jul 24;16(1):129. doi: 10.1186/s12943-017-0696-6.

Supplemental Content

Support Center